ZAFBENA
Live / Applied — Fifth extension granted (statement of use) (as of 10 Dec 2025)
What this means for you
Not registered yet, but its 20 Dec 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97180767
- Mark type
- Stylized text
- Filed
- 20 Dec 2021
- Published for opposition
- 01 Nov 2022
- Attorney of record
- Virginia W. Marino
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for use in oncology and pharmaceutical preparations to treat cancer
Owner
- BendaRx Corp., Alexandria, VA, US
- BendaRx Corp., Alexandria, VA, US
Prosecution history
- 11 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2025 — SOU EXTENSION 5 GRANTED
- 24 Jun 2025 — SOU EXTENSION 5 FILED
- 10 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 24 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2024 — SOU EXTENSION 4 GRANTED
- 09 Dec 2024 — SOU EXTENSION 4 FILED
- 09 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 24 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2024 — SOU EXTENSION 3 GRANTED
- 24 Jun 2024 — SOU EXTENSION 3 FILED
- 24 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 28 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Dec 2023 — SOU EXTENSION 2 GRANTED